DK0812845T3 - Fremgangsmåde til fremstilling af sildenafil - Google Patents

Fremgangsmåde til fremstilling af sildenafil

Info

Publication number: DK0812845T3
Authority: DK; Denmark
Prior art keywords: sildenafil; preparation
Prior art date: 1996-06-14

Application number

DK97303832T

Other languages

Danish (da)

English (en)

Inventor

Peter James Dunn

Albert Shaw Wood

Original Assignee

Pfizer Res & Dev

Pfizer Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-06-14

Filing date

1997-06-04

Publication date

1999-11-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10795332&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0812845(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-06-04 Application filed by Pfizer Res & Dev, Pfizer Ltd filed Critical Pfizer Res & Dev

1999-11-29 Application granted granted Critical

1999-11-29 Publication of DK0812845T3 publication Critical patent/DK0812845T3/da

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Urology & Nephrology (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Plural Heterocyclic Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Steroid Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

DK97303832T 1996-06-14 1997-06-04 Fremgangsmåde til fremstilling af sildenafil DK0812845T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9612514.1A GB9612514D0 (en)	1996-06-14	1996-06-14	Novel process

Publications (1)

Publication Number	Publication Date
DK0812845T3 true DK0812845T3 (da)	1999-11-29

Family

ID=10795332

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK97303832T DK0812845T3 (da)	1996-06-14	1997-06-04	Fremgangsmåde til fremstilling af sildenafil
DK98123740T DK0916675T3 (da)	1996-06-14	1997-06-04	Fremgangsmåde til fremstilling af sildenafil

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DK98123740T DK0916675T3 (da)	1996-06-14	1997-06-04	Fremgangsmåde til fremstilling af sildenafil

Country Status (48)

Country	Link
US (2)	US5955611A (es)
EP (2)	EP0812845B1 (es)
JP (2)	JP2866841B2 (es)
KR (1)	KR100207352B1 (es)
CN (2)	CN1106399C (es)
AP (1)	AP717A (es)
AR (1)	AR003401A1 (es)
AT (2)	ATE246194T1 (es)
AU (1)	AU697684B2 (es)
BG (1)	BG62554B1 (es)
BR (1)	BR9703580A (es)
CA (1)	CA2207694C (es)
CO (1)	CO4780028A1 (es)
CZ (1)	CZ290942B6 (es)
DE (2)	DE69723846T2 (es)
DK (2)	DK0812845T3 (es)
DZ (1)	DZ2247A1 (es)
EA (1)	EA000102B1 (es)
EG (1)	EG24123A (es)
ES (2)	ES2134051T3 (es)
GB (1)	GB9612514D0 (es)
GR (1)	GR3031087T3 (es)
HK (1)	HK1033459A1 (es)
HN (1)	HN1997000072A (es)
HR (1)	HRP970326B1 (es)
HU (1)	HU224497B1 (es)
ID (1)	ID18745A (es)
IL (3)	IL121000A (es)
IN (5)	IN187350B (es)
IS (2)	IS1922B (es)
MA (1)	MA24205A1 (es)
MX (1)	MX9704433A (es)
NO (2)	NO304551B1 (es)
NZ (1)	NZ328084A (es)
OA (1)	OA10426A (es)
PE (2)	PE20011303A1 (es)
PL (1)	PL189333B1 (es)
PT (1)	PT916675E (es)
RS (2)	RS49924B (es)
SA (1)	SA97180124B1 (es)
SG (1)	SG50024A1 (es)
SI (2)	SI0812845T1 (es)
SK (5)	SK283896B6 (es)
TN (1)	TNSN97102A1 (es)
TR (1)	TR199700470A2 (es)
UA (1)	UA27085C2 (es)
UY (2)	UY24585A1 (es)
ZA (1)	ZA975259B (es)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20060222647A1 (en) *	1993-05-27	2006-10-05	Beavo Joseph A	Methods and compositions for modulating the activity of PDE5
RS50118B (sr) *	1997-04-25	2009-03-25	Pfizer Inc.,	Pirazolopirimidinoni koji inhibiraju tip 5 ciklične guanozin 3',5'-monofosfat fosfo-diesteraze (cgmp pde5) za tretman seksualne disfunkcije
CN1309561A (zh) *	1997-05-29	2001-08-22	持田制药株式会社	勃起机能障碍治疗剂
US6399618B1 (en)	1997-07-09	2002-06-04	Cardiome Pharma Corp	Compositions and methods for modulating sexual activity
GB9722520D0 (en)	1997-10-24	1997-12-24	Pfizer Ltd	Compounds
CH693954A5 (de)	1997-11-12	2004-05-14	Bayer Ag	2-Phenyl-substituierte Imidazotriazinone als Phosphodiesterase Inhibitoren.
JP3721077B2 (ja)	1998-04-20	2005-11-30	ファイザー・インク	性的不全を治療するためのピラゾロピリミジノンｃＧＭＰＰＤＥ５阻害剤
CA2235642C (en)	1998-05-15	2007-11-13	Torcan Chemical Ltd.	Processes for preparing sildenafil
US6077841A (en) *	1998-09-04	2000-06-20	Janssen Pharmaceutica, N.V.	5-heterocyclyl pyrazolo[4,3-d]pyrimidin-7-ones for the treatment of male erectile dysfunction
GB9822238D0 (en) *	1998-10-12	1998-12-09	Pfizer Ltd	Process for preparation of pyrazolo[4,3-D]pyrimidin-7-ones and intermediates thereof
GB9823102D0 (en)	1998-10-23	1998-12-16	Pfizer Ltd	Pharmaceutically active compounds
GB9823103D0 (en) *	1998-10-23	1998-12-16	Pfizer Ltd	Pharmaceutically active compounds
GB9823101D0 (en)	1998-10-23	1998-12-16	Pfizer Ltd	Pharmaceutically active compounds
KR100353014B1 (ko) *	1998-11-11	2002-09-18	동아제약 주식회사	발기부전 치료에 효과를 갖는 피라졸로피리미디논 화합물
US6087362A (en) *	1999-03-16	2000-07-11	Pentech Pharmaceuticals, Inc.	Apomorphine and sildenafil composition
AU5204800A (en) *	1999-06-21	2001-01-09	Biochemical Pharmaceutical Factory of Zhuhai Sez, The	Process for preparing sildenafil, and troche which comprises sildenafil and apomorphine
CN1094492C (zh) *	1999-06-21	2002-11-20	杭州神鹰医药化工有限公司	西地那非的制备方法
CN1077108C (zh) *	1999-07-13	2002-01-02	成都地奥制药集团有限公司	用于制备药物昔多芬的前体化合物
WO2001019827A1 (en) *	1999-09-13	2001-03-22	Cipla Ltd.	A novel process for the synthesis of sildenafil citrate
US6075028A (en) *	1999-09-23	2000-06-13	Graham; Richard	Method of treating Tourette's syndrome and related CNS disorders
TWI265925B (en)	1999-10-11	2006-11-11	Pfizer	Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them
JP2003511452A (ja)	1999-10-11	2003-03-25	ファイザー・インク	ホスホジエステラーゼ阻害剤としての５−（２−置換−５−ヘテロシクリルスルホニルピリド−３−イル）−ジヒドロピラゾロ［４，３−ｄ］ピリミジン−７−オン
CA2411957C (en) *	2000-06-22	2007-09-18	Pfizer Inc.	Novel process for the preparation of pyrazolopyrimidinones
US6667398B2 (en)	2000-06-22	2003-12-23	Pfizer Inc	Process for the preparation of pyrazolopyrimidinones
US6730786B2 (en) *	2000-06-22	2004-05-04	Pfizer Inc	Process for the preparation of pyrazolopyrimidinones
GB0015462D0 (en) *	2000-06-22	2000-08-16	Pfizer Ltd	Novel process for the preparation of pyrazolopyrimidinones
EP1176147A1 (en) *	2000-07-28	2002-01-30	Pfizer Limited	Process for the preparation of pyrazolo[4,3-d]pyrimidin-7-ones and intermediates thereof
US6407259B1 (en)	2000-07-28	2002-06-18	Pfizer Inc.	Process for the preparation of pyrazoles
EP1176142A1 (en) *	2000-07-28	2002-01-30	Pfizer Inc.	Process for the preparation of pyrazoles
US6821978B2 (en) *	2000-09-19	2004-11-23	Schering Corporation	Xanthine phosphodiesterase V inhibitors
CN1127506C (zh) *	2001-06-29	2003-11-12	刘宝顺	一种治疗阳痿的新化合物
CA2457944C (en) *	2001-08-28	2009-09-29	Schering Corporation	Polycyclic guanine phosphodiesterase v inhibitors
EP1719772A1 (en)	2002-05-31	2006-11-08	Schering Corporation	Process for preparing xanthine phosphodiesterase v inhibitors and precursors thereof
DE10232113A1 (de)	2002-07-16	2004-01-29	Bayer Ag	Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
CN100374441C (zh)	2003-06-06	2008-03-12	天津倍方科技发展有限公司	二氢吡咯[2，3-d]嘧啶-4-酮衍生物，其制备方法及其制药用途
CN100360531C (zh) *	2003-12-18	2008-01-09	中国人民解放军军事医学科学院放射与辐射医学研究所	用于预防或治疗阳萎和性冷淡的新吡唑并嘧啶类化合物
EP1779852A3 (en) *	2004-01-05	2007-05-09	Teva Pharmaceutical Industries Ltd.	Processes for the production of sildenafil base and citrate salt
DE602005004966T2 (de) *	2004-01-05	2009-03-12	Teva Pharmaceutical Industries Ltd.	Prozesse zur herstellung von sildenafil-base und zitratsalz
DE102005009240A1 (de)	2005-03-01	2006-09-07	Bayer Healthcare Ag	Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
CN101563348B (zh) *	2006-12-21	2011-08-24	上海特化医药科技有限公司	西地那非的制备方法及其中间体
ES2310144B1 (es)	2007-06-15	2010-01-12	Galenicum Health, S.L.	Intermedios para la preparacion de un inhibidor de la fosfodiesterasa tipo 5.
BRPI0823356A2 (pt)	2008-12-12	2015-06-16	Rhein Siegfried Sa De Cv	Composição de liberação pulsátil de sildenafil e processo para prepará-la
MX2010006227A (es)	2010-06-07	2011-12-14	World Trade Imp Exp Wtie Ag	Nuevos derivados 1,4-diazepanos, inhibidores de pde-5.
CN102993205B (zh) *	2012-12-27	2015-04-15	华润赛科药业有限责任公司	一种高收率制备高纯度西地那非游离碱的纯化方法
CN103044330B (zh) *	2013-01-14	2018-11-13	常州亚邦制药有限公司	西地那非中间体4-氨基-1-甲基-3-正丙基吡唑-5-甲酰胺的绿色合成新工艺
CN105085526B (zh) *	2014-05-15	2017-08-01	重庆圣华曦药业股份有限公司	一种改进的西地那非制备方法
CN105753870B (zh) *	2016-04-01	2018-05-22	重庆康刻尔制药有限公司	一种西地那非杂质f及其制备方法和应用
WO2017168174A1 (en)	2016-04-02	2017-10-05	N4 Pharma Uk Limited	New pharmaceutical forms of sildenafil
CN105837578A (zh) *	2016-04-05	2016-08-10	重庆康刻尔制药有限公司	一种西地那非杂质d的合成方法
WO2018069316A2 (en)	2016-10-10	2018-04-19	Transgene Sa	Immunotherapeutic product and mdsc modulator combination therapy
CN113493459B (zh) *	2020-04-07	2022-12-13	广州白云山医药集团股份有限公司白云山制药总厂	Pde5抑制剂化合物及其制备方法和应用
CN112961160A (zh) *	2021-03-05	2021-06-15	遂成药业股份有限公司	一种西地那非的改良合成工艺
CN113754612B (zh) *	2021-10-26	2023-09-26	山东安舜制药有限公司	一种西地那非中间体的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4871843A (en) *	1983-10-18	1989-10-03	Dropic-Societe Civile De Gestion De Droits De Propriete Industrielle	Cyclic benzenesulfonamides, process for their preparation and their use as active substance of pharmaceutical compositions
GB9013750D0 (en) *	1990-06-20	1990-08-08	Pfizer Ltd	Therapeutic agents
GB9114760D0 (en) *	1991-07-09	1991-08-28	Pfizer Ltd	Therapeutic agents
GB9311920D0 (en) *	1993-06-09	1993-07-28	Pfizer Ltd	Therapeutic agents
RS50118B (sr) *	1997-04-25	2009-03-25	Pfizer Inc.,	Pirazolopirimidinoni koji inhibiraju tip 5 ciklične guanozin 3',5'-monofosfat fosfo-diesteraze (cgmp pde5) za tretman seksualne disfunkcije
US6087368A (en) *	1998-06-08	2000-07-11	Bristol-Myers Squibb Company	Quinazolinone inhibitors of cGMP phosphodiesterase

1996
- 1996-06-14 GB GBGB9612514.1A patent/GB9612514D0/en active Pending
1997
- 1997-05-14 HN HN1997000072A patent/HN1997000072A/es unknown
- 1997-05-30 NO NO972481A patent/NO304551B1/no not_active IP Right Cessation
- 1997-06-02 AP APAP/P/1997/001009A patent/AP717A/en active
- 1997-06-04 ES ES97303832T patent/ES2134051T3/es not_active Expired - Lifetime
- 1997-06-04 EP EP97303832A patent/EP0812845B1/en not_active Expired - Lifetime
- 1997-06-04 AT AT98123740T patent/ATE246194T1/de active
- 1997-06-04 SI SI9730005T patent/SI0812845T1/xx not_active IP Right Cessation
- 1997-06-04 PT PT98123740T patent/PT916675E/pt unknown
- 1997-06-04 DE DE69723846T patent/DE69723846T2/de not_active Expired - Lifetime
- 1997-06-04 EP EP98123740A patent/EP0916675B1/en not_active Expired - Lifetime
- 1997-06-04 AT AT97303832T patent/ATE182150T1/de active
- 1997-06-04 DE DE69700321T patent/DE69700321T2/de not_active Expired - Lifetime
- 1997-06-04 DK DK97303832T patent/DK0812845T3/da active
- 1997-06-04 SI SI9730577T patent/SI0916675T1/xx unknown
- 1997-06-04 DK DK98123740T patent/DK0916675T3/da active
- 1997-06-04 ES ES98123740T patent/ES2201397T3/es not_active Expired - Lifetime
- 1997-06-05 IL IL12100097A patent/IL121000A/xx not_active IP Right Cessation
- 1997-06-05 BG BG101569A patent/BG62554B1/bg unknown
- 1997-06-05 IL IL12541197A patent/IL125411A/xx not_active IP Right Cessation
- 1997-06-05 TR TR97/00470A patent/TR199700470A2/xx unknown
- 1997-06-06 US US08/869,532 patent/US5955611A/en not_active Expired - Lifetime
- 1997-06-10 SK SK1786-2001A patent/SK283896B6/sk not_active IP Right Cessation
- 1997-06-10 SK SK743-97A patent/SK283893B6/sk not_active IP Right Cessation
- 1997-06-10 SK SK1787-2001A patent/SK283897B6/sk not_active IP Right Cessation
- 1997-06-10 SA SA97180124A patent/SA97180124B1/ar unknown
- 1997-06-10 SK SK1783-2001A patent/SK283894B6/sk not_active IP Right Cessation
- 1997-06-10 IS IS4503A patent/IS1922B/is unknown
- 1997-06-10 IN IN1548DE1997 patent/IN187350B/en unknown
- 1997-06-10 SK SK1784-2001A patent/SK283895B6/sk not_active IP Right Cessation
- 1997-06-11 PE PE2001000983A patent/PE20011303A1/es not_active IP Right Cessation
- 1997-06-11 PE PE1997000483A patent/PE1299A1/es not_active IP Right Cessation
- 1997-06-11 TN TNTNSN97102A patent/TNSN97102A1/fr unknown
- 1997-06-11 DZ DZ970097A patent/DZ2247A1/fr active
- 1997-06-11 MA MA24655A patent/MA24205A1/fr unknown
- 1997-06-11 EA EA199700061A patent/EA000102B1/ru not_active IP Right Cessation
- 1997-06-12 ID IDP972004A patent/ID18745A/id unknown
- 1997-06-12 AR ARP970102564A patent/AR003401A1/es unknown
- 1997-06-12 UA UA97062802A patent/UA27085C2/uk unknown
- 1997-06-12 CA CA002207694A patent/CA2207694C/en not_active Expired - Lifetime
- 1997-06-12 EG EG54097A patent/EG24123A/xx active
- 1997-06-12 CZ CZ19971811A patent/CZ290942B6/cs not_active IP Right Cessation
- 1997-06-12 SG SG1997002037A patent/SG50024A1/en unknown
- 1997-06-13 JP JP9156422A patent/JP2866841B2/ja not_active Expired - Lifetime
- 1997-06-13 AU AU24878/97A patent/AU697684B2/en not_active Ceased
- 1997-06-13 MX MX9704433A patent/MX9704433A/es unknown
- 1997-06-13 HR HR970326A patent/HRP970326B1/xx not_active IP Right Cessation
- 1997-06-13 PL PL97320555A patent/PL189333B1/pl not_active IP Right Cessation
- 1997-06-13 KR KR1019970024457A patent/KR100207352B1/ko not_active IP Right Cessation
- 1997-06-13 ZA ZA9705259A patent/ZA975259B/xx unknown
- 1997-06-13 NZ NZ328084A patent/NZ328084A/en not_active IP Right Cessation
- 1997-06-13 CO CO97032741A patent/CO4780028A1/es unknown
- 1997-06-13 CN CN97113261A patent/CN1106399C/zh not_active Expired - Lifetime
- 1997-06-13 RS YUP-2006/0484A patent/RS49924B/sr unknown
- 1997-06-13 OA OA70024A patent/OA10426A/en unknown
- 1997-06-13 RS YUP-254/97A patent/RS49653B/sr unknown
- 1997-06-13 UY UY24585A patent/UY24585A1/es not_active IP Right Cessation
- 1997-06-13 HU HU9701048A patent/HU224497B1/hu not_active IP Right Cessation
- 1997-06-16 BR BR9703580A patent/BR9703580A/pt not_active IP Right Cessation
- 1997-07-09 UY UY24612A patent/UY24612A1/es not_active IP Right Cessation
1998
- 1998-07-20 IL IL12541198A patent/IL125411A0/xx unknown
- 1998-09-25 JP JP10271067A patent/JP3058863B2/ja not_active Expired - Lifetime
- 1998-10-30 NO NO985064A patent/NO306115B1/no not_active IP Right Cessation
1999
- 1999-07-23 US US09/360,128 patent/US6066735A/en not_active Expired - Lifetime
- 1999-08-26 GR GR990402170T patent/GR3031087T3/el unknown
2000
- 2000-07-05 CN CNB001200542A patent/CN1149206C/zh not_active Expired - Lifetime
2001
- 2001-04-24 IN IN520DE2001 patent/IN187320B/en unknown
- 2001-04-24 IN IN518DE2001 patent/IN187318B/en unknown
- 2001-04-24 IN IN519DE2001 patent/IN187319B/en unknown
- 2001-04-24 IN IN517DE2001 patent/IN187317B/en unknown
- 2001-06-15 HK HK01104141A patent/HK1033459A1/xx not_active IP Right Cessation
2002
- 2002-11-25 IS IS6634A patent/IS1923B/is unknown

Also Published As

Publication number	Publication date
SK74397A3 (en)	1998-06-03
HRP970326A2 (en)	1998-06-30
SG50024A1 (en)	1998-06-15
DE69723846D1 (de)	2003-09-04
EP0916675B1 (en)	2003-07-30
AP717A (en)	1999-01-04
DZ2247A1 (fr)	2002-12-18
ES2134051T3 (es)	1999-09-16
JP3058863B2 (ja)	2000-07-04
AU2487897A (en)	1997-12-18
US5955611A (en)	1999-09-21
ZA975259B (en)	1997-12-15
IL121000A0 (en)	1997-11-20
GB9612514D0 (en)	1996-08-14
EA000102B1 (ru)	1998-08-27
DE69723846T2 (de)	2004-03-04
RS49924B (sr)	2008-09-29
MA24205A1 (fr)	1997-12-31
EP0916675A3 (en)	1999-07-14
GR3031087T3 (en)	1999-12-31
IN187319B (es)	2002-03-23
IN187350B (es)	2002-03-30
AP9701009A0 (en)	1997-07-31
BG62554B1 (bg)	2000-02-29
IN187320B (es)	2002-03-23
SI0916675T1 (en)	2003-12-31
AU697684B2 (en)	1998-10-15
JP2866841B2 (ja)	1999-03-08
SK283896B6 (sk)	2004-04-06
KR100207352B1 (en)	1999-07-15
JPH11171879A (ja)	1999-06-29
EP0812845B1 (en)	1999-07-14
NO306115B1 (no)	1999-09-20
CZ181197A3 (cs)	1998-03-18
NO304551B1 (no)	1999-01-11
SA97180124A (ar)	2005-12-03
DE69700321D1 (de)	1999-08-19
HN1997000072A (es)	1997-12-26
PE20011303A1 (es)	2001-12-25
IN187318B (es)	2002-03-23
BR9703580A (pt)	1998-11-10
NO972481D0 (no)	1997-05-30
HK1033459A1 (en)	2001-08-31
ATE246194T1 (de)	2003-08-15
CN1282740A (zh)	2001-02-07
IS6634A (is)	2002-11-25
NO985064D0 (no)	1998-10-30
AR003401A1 (es)	1998-08-05
EP0812845A1 (en)	1997-12-17
BG101569A (en)	1998-01-30
ATE182150T1 (de)	1999-07-15
PT916675E (pt)	2003-11-28
IS4503A (is)	1997-12-15
UY24612A1 (es)	2000-09-29
KR980002051A (ko)	1998-03-30
SA97180124B1 (ar)	2006-02-08
HRP970326B1 (en)	2000-10-31
US6066735A (en)	2000-05-23
CO4780028A1 (es)	1999-05-26
HUP9701048A2 (hu)	1998-12-28
RS20060484A (en)	2007-04-10
DE69700321T2 (de)	1999-11-04
PE1299A1 (es)	1999-01-13
IL125411A0 (en)	1999-03-12
CN1149206C (zh)	2004-05-12
NO972481L (no)	1997-12-15
SK283894B6 (sk)	2004-04-06
UY24585A1 (es)	1997-12-02
CZ290942B6 (cs)	2002-11-13
TNSN97102A1 (fr)	2005-03-15
IL121000A (en)	2000-02-29
UA27085C2 (uk)	2000-02-28
IS1922B (is)	2004-03-15
NZ328084A (en)	1998-08-26
DK0916675T3 (da)	2003-10-27
HU224497B1 (hu)	2005-10-28
PL320555A1 (en)	1997-12-22
PL189333B1 (pl)	2005-07-29
ES2201397T3 (es)	2004-03-16
JPH1081688A (ja)	1998-03-31
CN1168376A (zh)	1997-12-24
HU9701048D0 (en)	1997-08-28
MX9704433A (es)	1998-11-30
ID18745A (id)	1998-05-07
EP0916675A2 (en)	1999-05-19
YU25497A (sh)	1998-12-23
SI0812845T1 (en)	1999-12-31
IS1923B (is)	2004-03-15
TR199700470A2 (xx)	1998-01-21
CA2207694A1 (en)	1997-12-14
SK283893B6 (sk)	2004-04-06
IN187317B (es)	2002-03-23
HUP9701048A3 (en)	2000-10-30
RS49653B (sr)	2007-09-21
IL125411A (en)	2000-02-29
SK283897B6 (sk)	2004-04-06
CN1106399C (zh)	2003-04-23
EA199700061A1 (ru)	1997-12-30
NO985064L (no)	1997-12-15
OA10426A (en)	2001-12-07
SK283895B6 (sk)	2004-04-06
EG24123A (en)	2008-07-06
CA2207694C (en)	1999-11-23

Publication	Publication Date	Title
DK0916675T3 (da)	2003-10-27	Fremgangsmåde til fremstilling af sildenafil
DK0790226T3 (da)	2000-08-07	Fremgangsmåde til fremstilling af methanol
DK0770615T3 (da)	2003-07-14	Fremgangsmåde til fremstilling af dihalogenazolopyrimidiner
DK1032566T5 (da)	2004-06-28	Fremgangsmåde til fremstilling af citalopram
DK1038008T3 (da)	2007-03-12	Fremgangsmåde til fremstilling af EGIII-lignende enzymer
DK0937055T3 (da)	2002-07-29	Fremgangsmåde til fremstilling af d,I-alfa-tocopherol
DK0939749T3 (da)	2001-11-05	Fremgangsmåde til fremstilling af benzylethere
DK0775100T3 (da)	2000-11-27	Fremgangsmåde til fremstilling af trifluorethylen
DK0756597T3 (da)	2001-08-20	Fremgangsmåde til fremstilling af puriner
DK0768310T3 (da)	2000-04-17	Fremgangsmåde til fremstilling af imidazo-benzodiazepin-derivater
DK1053217T3 (da)	2003-09-15	Fremgangsmåde til fremstilling af n-propanol
DK1027315T3 (da)	2003-09-29	Fremgangsmåde til fremstilling af n-butanol
DK0996642T3 (da)	2006-05-08	Fremgangsmåde til fremstilling af heparin
DK0877738T3 (da)	2003-09-08	Fremgangsmåde til fremstilling af phenylimidazolidinderivater
DK1028960T3 (da)	2003-08-11	Fremgangsmåde til fremstilling af thiazolidinedion
DK0912603T3 (da)	2004-02-09	Fremgangsmåde til fremstilling af visse azacyclohexapeptider
DK0970939T3 (da)	2003-04-07	Fremgangsmåde til fremstilling af methanol
DK0946514T3 (da)	2003-08-25	Fremgangsmåde til fremstilling af n-substituerede 3-hydroxypyrazoler
DK0880498T3 (da)	2002-05-21	Fremgangsmåde til fremstilling af diketonforbindelser
DK0864564T3 (da)	2002-09-23	Særlig fremgangsmåde til fremstillingen af alfa-bromlactamderivater
DK0973769T3 (da)	2004-12-13	Fremgangsmåde til fremstilling af eprosartan
DK0927766T3 (da)	2006-09-04	Enzymatisk fremgangsmåde til fremstilling af (S)-cyanhydriner
DK0970073T3 (da)	2005-02-21	Fremgangsmåde til fremstilling af eprosartan
DK0648738T3 (da)	1997-06-16	Fremgangsmåde til fremstilling af acetoacetarylamider
DK1012152T3 (da)	2003-02-10	Fremgangsmåde til fremstilling af oxazaphosphorin-2-aminer